bacampicillin and Streptococcal-Infections

bacampicillin has been researched along with Streptococcal-Infections* in 2 studies

Trials

1 trial(s) available for bacampicillin and Streptococcal-Infections

Article	Year
Clinical trial of bacampicillin in acute bacterial infections. Clinical therapeutics, 1983, Volume: 5, Issue:5 A clinical trial of bacampicillin was carried out in 20 patients. The antibiotic was found to be effective in acute lobar pneumonia, pyogenic meningitis, acute and chronic bronchitis, acute pharyngitis, acute tonsillitis, cellulitis, furunculosis, and pyomyositis caused by such ampicillin-sensitive organisms as Neisseria meningitidis, Diplococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Streptococcus pyogenes, Klebsiella pneumoniae, and Escherichia coli. Rash in three patients was the only side effect encountered. It is concluded that while bacampicillin may have overcome some of the disadvantages of ampicillin, it retains its main attributes and some shortcomings. Topics: Adolescent; Adult; Aged; Ampicillin; Bacterial Infections; Bronchitis; Cellulitis; Child; Clinical Trials as Topic; Female; Furunculosis; Haemophilus Infections; Humans; Male; Meningitis; Middle Aged; Pharyngitis; Pneumonia, Pneumococcal; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Tonsillitis	1983

Article

Year

Clinical trial of bacampicillin in acute bacterial infections.

Clinical therapeutics, 1983, Volume: 5, Issue:5

A clinical trial of bacampicillin was carried out in 20 patients. The antibiotic was found to be effective in acute lobar pneumonia, pyogenic meningitis, acute and chronic bronchitis, acute pharyngitis, acute tonsillitis, cellulitis, furunculosis, and pyomyositis caused by such ampicillin-sensitive organisms as Neisseria meningitidis, Diplococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Streptococcus pyogenes, Klebsiella pneumoniae, and Escherichia coli. Rash in three patients was the only side effect encountered. It is concluded that while bacampicillin may have overcome some of the disadvantages of ampicillin, it retains its main attributes and some shortcomings.

Topics: Adolescent; Adult; Aged; Ampicillin; Bacterial Infections; Bronchitis; Cellulitis; Child; Clinical Trials as Topic; Female; Furunculosis; Haemophilus Infections; Humans; Male; Meningitis; Middle Aged; Pharyngitis; Pneumonia, Pneumococcal; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Tonsillitis

1983

Other Studies

1 other study(ies) available for bacampicillin and Streptococcal-Infections

Article	Year
Ampicillin concentrations in human radicular granuloma following a single oral dose of bacampicillin. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 1992, Volume: 50, Issue:1 Ampicillin concentrations in human serum and radicular granulomas of 42 patients were determined after a single oral dose of bacampicillin (equivalent to 500 mg of ampicillin). Although wide variations were found among both serum and radicular granuloma ampicillin concentrations, measurable concentrations were found in all cases. The mean peak ampicillin concentrations in serum and radicular granulomas occurred at identical times, 1.5 hours, and were 11.19 micrograms/mL (range, 1.30 to 21.00 micrograms/mL) and 5.12 micrograms/g (range, 0.50 to 10.50 micrograms/g), respectively. The mean radicular granuloma/serum ampicillin concentration ratio at the peak time was 0.42. Ampicillin concentrations in radicular granulomas exceeded most of the minimum inhibitory concentrations for bacteria commonly isolated from odontogenic infections. Topics: Administration, Oral; Adult; Ampicillin; Biological Availability; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Periapical Granuloma; Streptococcal Infections; Streptococcus	1992

Article

Year

Ampicillin concentrations in human radicular granuloma following a single oral dose of bacampicillin.

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 1992, Volume: 50, Issue:1

Ampicillin concentrations in human serum and radicular granulomas of 42 patients were determined after a single oral dose of bacampicillin (equivalent to 500 mg of ampicillin). Although wide variations were found among both serum and radicular granuloma ampicillin concentrations, measurable concentrations were found in all cases. The mean peak ampicillin concentrations in serum and radicular granulomas occurred at identical times, 1.5 hours, and were 11.19 micrograms/mL (range, 1.30 to 21.00 micrograms/mL) and 5.12 micrograms/g (range, 0.50 to 10.50 micrograms/g), respectively. The mean radicular granuloma/serum ampicillin concentration ratio at the peak time was 0.42. Ampicillin concentrations in radicular granulomas exceeded most of the minimum inhibitory concentrations for bacteria commonly isolated from odontogenic infections.

Topics: Administration, Oral; Adult; Ampicillin; Biological Availability; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Periapical Granuloma; Streptococcal Infections; Streptococcus

1992